Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 20/20 | 0.55 |
| ▸ | PIM3 | Q86V86 | 20/20 | 0.55 |
| ▸ | PIM2 | Q9P1W9 | 20/20 | 0.55 |
| ▸ | GSK3B | P49841 | 1/20 | 0.54 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10278752 | 1.00 | PIM1 (0.55) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL319494 | 1.00 | PIM1 (0.55) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL319325 | 0.88 | PIM1 (0.57) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL1910584 | 0.86 | PIM1 (0.60) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL1910791 | 0.86 | PIM1 (0.60) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL319072 | 0.86 | PIM1 (0.60) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL10278834 | 0.81 | PIM1 (0.66) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL1911214 | 0.81 | PIM1 (0.59) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL1910932 | 0.76 | PIM1 (0.60) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL14893047 | 0.76 | PIM1 (0.60) | PIM1PIM3PIM2GSK3BPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012004217-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |